SARSEQ > Imprint

Imprint aims to cater to the needs of potential users of SARSEQ as a mean to detect SARS-CoV-2. It presents information gathered by scientists around Ulrich Elling (Institute of Molecular Biotechnology), Luisa Cochella, and Alexander Stark (both Research Institute of Molecular Pathology) at the Vienna BioCenter. The work underlying this website was a joint effort of their institute-crossing team.

Forschungsinstitut für Molekulare Pathologie GmbH (IMP) 
Campus-Vienna-Biocenter 1, A-1030 Wien 
Tel: +43 (1) 797 30 
Fax: +43 (1) 798 71 53

Jan-Michael Peters, Managing Director Science
Harald Isemann, Managing Director Administration and Finance

Unternehmensgegenstand: Grundlagen-Forschungsinstitut
Handelsgericht Wien
UID Nr. ATU14238608

All contents on this website are subject to copyrights.

Photo Credit
IMP/Lukas Beck
Peter Duchek